LJI home to new “Center of Excellence”
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are about to get an even closer look at disease-fighting
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are about to get an even closer look at disease-fighting
The new Reina Lab aims to charge up killer T cells against tumors
"The potential for a 'cure from within' is in every cancer patient we've looked at..."
LJI researchers investigate a group of T cells known for their unusual response to pathogens
LJI researchers shed light on the role of TET enzymes in genomic stability and cancers
The international recognition reflects how LJI research is valued by scientific peers
Now we can see what they see — and help
New LJI research could keep cancer-fighting T cells from burning out before the job is done
LJI scientists develop new tool for understanding enzymatic activity linked to blood cancers and heart disease
Treating patients with anti-CTLA4 therapies prior to anti-PD1 treatment may be a promising strategy
National Cancer Institute support brings cancer researchers together to share key findings
Dr. Altman’s research into T cell activation opened the door to new therapies for inflammation, autoimmune diseases, cancers, and more.